Abbott Laboratories Statistics

Total Valuation

BCBA:ABT has a market cap or net worth of ARS 286.67 trillion. The enterprise value is 294.88 trillion.

Market Cap	286.67T
Enterprise Value	294.88T

Important Dates

The next estimated earnings date is Thursday, July 17, 2025.

Earnings Date	Jul 17, 2025
Ex-Dividend Date	May 17, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.06%
Shares Change (QoQ)	+0.07%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.73B

Valuation Ratios

The trailing PE ratio is 19.86 and the forward PE ratio is 25.04.

PE Ratio	19.86
Forward PE	25.04
PS Ratio	6.31
PB Ratio	5.44
P/TBV Ratio	13.92
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 21.13, with an EV/FCF ratio of 41.28.

EV / Earnings	20.43
EV / Sales	5.68
EV / EBITDA	21.13
EV / EBIT	30.64
EV / FCF	41.28

Financial Position

The company has a current ratio of 1.78, with a Debt / Equity ratio of 0.27.

Current Ratio	1.78
Quick Ratio	1.09
Debt / Equity	0.27
Debt / EBITDA	1.17
Debt / FCF	2.00
Interest Coverage	14.30

Financial Efficiency

Return on equity (ROE) is 30.65% and return on invested capital (ROIC) is 8.45%.

Return on Equity (ROE)	30.65%
Return on Assets (ROA)	6.38%
Return on Invested Capital (ROIC)	8.45%
Return on Capital Employed (ROCE)	11.47%
Revenue Per Employee	398.59M
Profits Per Employee	126.62M
Employee Count	114,000
Asset Turnover	0.55
Inventory Turnover	2.77

Taxes

Income Tax	-6,596.35B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +27.60% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+27.60%
50-Day Moving Average	39,496.50
200-Day Moving Average	37,069.13
Relative Strength Index (RSI)	54.46
Average Volume (20 Days)	345

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.12

Income Statement

In the last 12 months, BCBA:ABT had revenue of ARS 45.44 trillion and earned 14.43 trillion in profits. Earnings per share was 8,264.67.

Revenue	45.44T
Gross Profit	25.44T
Operating Income	8.43T
Pretax Income	7.89T
Net Income	14.43T
EBITDA	11.83T
EBIT	8.43T
Earnings Per Share (EPS)	8,264.67

Full Income Statement

Balance Sheet

The company has 7.34 trillion in cash and 14.26 trillion in debt, giving a net cash position of -6,917.20 billion.

Cash & Cash Equivalents	7.34T
Total Debt	14.26T
Net Cash	-6,917.20B
Net Cash Per Share	n/a
Equity (Book Value)	52.65T
Book Value Per Share	30,105.75
Working Capital	10.89T

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 9.60 trillion and capital expenditures -2,460.62 billion, giving a free cash flow of 7.14 trillion.

Operating Cash Flow	9.60T
Capital Expenditures	-2,460.62B
Free Cash Flow	7.14T
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 55.99%, with operating and profit margins of 18.54% and 31.89%.

Gross Margin	55.99%
Operating Margin	18.54%
Pretax Margin	17.37%
Profit Margin	31.89%
EBITDA Margin	26.03%
EBIT Margin	18.54%
FCF Margin	15.72%

Dividends & Yields

This stock pays an annual dividend of 541.76, which amounts to a dividend yield of 1.32%.

Dividend Per Share	541.76
Dividend Yield	1.32%
Dividend Growth (YoY)	155.54%
Years of Dividend Growth	11
Payout Ratio	28.92%
Buyback Yield	0.06%
Shareholder Yield	1.39%
Earnings Yield	5.04%
FCF Yield	2.49%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on October 22, 2020. It was a forward split with a ratio of 2.

Last Split Date	Oct 22, 2020
Split Type	Forward
Split Ratio	2

Scores

BCBA:ABT has an Altman Z-Score of 5.49 and a Piotroski F-Score of 5.

Altman Z-Score	5.49
Piotroski F-Score	5